je.st
news
Nivalis Therapeutics A No-Brainer For Biotech Investors
2015-06-15 22:09:24| Biotech - Topix.net
Nivalis Therapeutics is a mid-clinical trial stage pharmaceutical company working with therapies that target certain gene mutations in cystic fibrosis patients. The company is preparing for its initial public offering to raise funds for continuing clinical trials and research.
Tags: investors
biotech
therapeutics
nobrainer
Category:Biotechnology and Pharmaceuticals